2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1063778868 M.D.
Verify on CMS →

Kara Mizokami-Stout, M.D.

Endocrinology, Diabetes & Metabolism Physician in Ann Arbor, Michigan. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
674
Medicare Part D claims · 89 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
46%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$217.06
5 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Kara Mizokami-Stout, M.D. filed 674 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Ann Arbor, Michigan, prescribing 46% generic.

674
Part D claims, 2023
46%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Kara Mizokami-Stout, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

674 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Kara Mizokami-Stout, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Kara Mizokami-Stout, M.D.?

Quality data not reported

NPI registry status

Active

Issued 04/05/2012

NPI 1063778868

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

674 74% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Michigan

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Michigan providers

Michigan providers
Behavior Technician - 21.4%Behavior Technician21.4%Clinical Social Worker - 5.8%Clinical Social Worker5.8%Student in an Organized Health Care Education/Training Program - 3.6%Student in an Organized Health Care Education/Training Program3.6%Physical Therapist - 3.4%Physical Therapist3.4%Social Worker - 3.4%Social Worker3.4%Pharmacist - 3%Pharmacist3%Endocrinology, Diabetes & Metabolism Physician - 0.1%Endocrinology, Diabetes & Metabolism Physician0.1%
Largest specialties in Michigan (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Kara Mizokami-Stout, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 24 FRANK LLOYD WRIGHT DR, Ann Arbor, MI, 48105, with a listed phone of (734) 647-5871. NPI 1063778868 was issued on 04/05/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Mizokami-Stout most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 674 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $382K in drug spend, split 44% brand-name and 46% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

24 FRANK LLOYD WRIGHT DR
Ann Arbor, MI 48105

Provider Details

NPI 1063778868
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 04/05/2012

Hospital and facility affiliations

Facilities where Kara Mizokami-Stout, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Regents OF The University OF Michigan
Ann Arbor, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kara Mizokami-Stout, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$217

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Michigan MI-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Kara Mizokami-Stout, M.D.. To verify Kara Mizokami-Stout, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Kara Mizokami-Stout, M.D. - brand share 44.0%
Endocrinology, Diabetes & Metabolism Physician average

44% brand-name claims vs 46% generic, on 674 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

674
Total Claims
$382K
Total Drug Cost
89
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,748
Total Day Supply
51,939
Brand vs Generic
44% brand / 46% generic
Brand Drug Cost
$358K
Generic Drug Cost
$14K

Patient Demographics

Average Patient Age
69.9 years
Avg HCC Risk Score
1.63
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Kara Mizokami-Stout, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
96
Jardiance
Empagliflozin
37
Novolog Flexpen
Insulin Aspart
36
Amlodipine Besylate
29
Methimazole
23
Ozempic
Semaglutide
23
Alendronate Sodium
22
Metformin Hcl
21
Rosuvastatin Calcium
19
Atorvastatin Calcium
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Kara Mizokami-Stout, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Kara Mizokami-Stout, M.D.'s 674 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Mizokami-Stout.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Kara Mizokami-Stout, M.D.'s specialty?
Kara Mizokami-Stout, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Ann Arbor, Michigan. Credentials: M.D..
How much does Kara Mizokami-Stout, M.D. prescribe under Medicare Part D?
In 2023, Kara Mizokami-Stout, M.D. wrote 674 Medicare Part D claims totaling $382K in drug costs for 89 beneficiaries.
Where is Kara Mizokami-Stout, M.D. located?
Kara Mizokami-Stout, M.D. is located at 24 FRANK LLOYD WRIGHT DR, Ann Arbor, MI, 48105. Phone: (734) 647-5871.
What is Kara Mizokami-Stout, M.D.'s NPI number?
Kara Mizokami-Stout, M.D.'s National Provider Identifier (NPI) is 1063778868, issued on 04/05/2012.
Does Kara Mizokami-Stout, M.D. prescribe more brand-name or generic drugs?
Kara Mizokami-Stout, M.D.'s prescribing is 44% brand-name and 46% generic drugs by claim count, with $358K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Kara Mizokami-Stout, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Kara Mizokami-Stout, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Jardiance, Novolog Flexpen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kara Mizokami-Stout, M.D. accept Medicare?
Kara Mizokami-Stout, M.D. appears in CMS Medicare data with 674 Part D claims and 89 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kara Mizokami-Stout, M.D.'s credentials?
Kara Mizokami-Stout, M.D.'s NPI is 1063778868 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.